These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16425979)

  • 1. Blockade by nifedipine of advanced glycation end product-induced CD40-CD40 ligand interaction in endothelial cells.
    Yamagishi S; Kikuchi S; Takenaka K; Takeuchi M
    Drugs Exp Clin Res; 2005; 31(5-6):221-6. PubMed ID: 16425979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
    Yamagishi S; Takeuchi M
    Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine inhibits tumor necrosis factor-alpha-induced upregulation of monocyte chemoattractant protein-1 mRNA levels by suppressing CD40 expression in endothelial cells.
    Yamagishi S; Takeuchi M
    Drugs Exp Clin Res; 2005; 31(1):13-7. PubMed ID: 15921025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.
    Yamagishi S; Matsui T; Ueda S; Takeuchi M
    Int J Cardiol; 2010 Oct; 144(2):283-5. PubMed ID: 19237211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetic vascular calcification by nifedipine, a dihydropyridine-based calcium channel blocker.
    Yamagishi S; Matsui T; Nakamura K
    Med Hypotheses; 2007; 68(5):1096-8. PubMed ID: 17097822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(2):392-4. PubMed ID: 15922119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone decreased CD40/CD40L expression on human umbilical vein endothelial cells induced by oxidized low-density lipoprotein.
    Jiang DQ; Chu LX; Liu ZY; Zhang SB
    Clin Chim Acta; 2006 Aug; 370(1-2):94-9. PubMed ID: 16545355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.
    Yamagishi S; Matsui T; Nakamura K; Takeuchi M
    Int J Tissue React; 2005; 27(4):189-95. PubMed ID: 16440584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.
    Yamagishi S; Matsui T; Inoue H
    Drugs Exp Clin Res; 2005; 31(5-6):227-32. PubMed ID: 16425980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators.
    Meng D; Liu N
    Chin Med J (Engl); 2003 Sep; 116(9):1336-40. PubMed ID: 14527361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
    Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
    Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone inhibits CD40/CD40L expression on human umbilical vein endothelial cells induced by interferon gamma.
    Li Y; Xia Z; Wang M
    Int Immunopharmacol; 2009 Feb; 9(2):168-72. PubMed ID: 19015047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 and CD40L expression in the chicken embryo aorta: possible role in the endothelial-mesenchymal transdifferentiation process.
    Arciniegas E; Becerra A; De Sanctis JB; Graterol A; Ramírez R
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Oct; 274(2):942-51. PubMed ID: 12973718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells.
    Stitt AW; He C; Vlassara H
    Biochem Biophys Res Commun; 1999 Mar; 256(3):549-56. PubMed ID: 10080935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway.
    Geraldes P; Gagnon S; Hadjadj S; Merhi Y; Sirois MG; Cloutier I; Tanguay JF
    Cardiovasc Res; 2006 Aug; 71(3):566-73. PubMed ID: 16797503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
    Zhang FL; Gao HQ; Shen L
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells.
    Zhang FL; Gao HQ; Wu JM; Ma YB; You BA; Li BY; Xuan JH
    J Cardiovasc Pharmacol; 2006 Aug; 48(2):47-53. PubMed ID: 16954821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.